WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced a publication in Blood Cancer Journal, a peer-reviewed journal that focuses on hematologic malignancies and related disorders. The manuscript “Lack of intrafollicular memory CD4+ T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma” underscores the role of intrafollicular CD4